[1]方敏 张新 曹轶 吴云艳 赵永波 马冬.腺苷脱氨酶对急性Stanford A型主动脉夹层患者术后短期死亡风险预测的研究[J].心血管病学进展,2025,(4):356.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.016]
　FANG Min,ZHANG Xin,CAO Yi,et al.Predictive Value of Adenosine Deaminase for Early Postoperative Death in Patients with Acute Stanford Type A Aortic Dissection[J].Advances in Cardiovascular Diseases,2025,(4):356.[doi:10.16806/j.cnki.issn.1004-3934.2024.04.016]
点击复制

腺苷脱氨酶对急性Stanford A型主动脉夹层患者术后短期死亡风险预测的研究()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2025年4期
页码:
356
栏目:
论著
出版日期:
2025-04-25

文章信息/Info

Title:
Predictive Value of Adenosine Deaminase for Early Postoperative Death in Patients with Acute Stanford Type A Aortic Dissection
作者:
方敏1; 3 张新1 曹轶1 吴云艳2 赵永波2 马冬1; 3
(1.华北理工大学公共卫生学院,河北 唐山 063210;2. 河北医科大学第四医院心血管外科,河北 石家庄051000;3. 神经与血管生物学教育部重点实验室 河北省心血管稳态与衰老重点实验室 河北医科大学基础生化所,河北 石家庄 050017)
Author(s):
FANG Min1; 3;  ZHANG Xin1;  CAO Yi1;  WU Yunyan2;  ZHAO Yongbo2*;  MA Dong1; 3*
(1.School of Public Health, North China University of Science and Technology, Tangshan 063210, Hebei, China;2. Cardiac Surgery Department, The Fourth Hospital of Hebei Medical University, Shijiazhuang 051000, Hebei, China;3. Department of Biochemistry and Molecular Biology, Key Laboratory of Neural and Vascular Biology, Ministry of Education, and Hebei Key Laboratory of Cardiovascular Homeostasis and Aging, Hebei Medical University, Shijiazhuang 050017, Hebei, China)
关键词:
急性Stanford A型主动脉夹层; 腺苷脱氨酶; 院内死亡
Keywords:
Acute Stanford type A aortic dissection;  Adenosine deaminase;  In-hospital mortality
DOI:
10.16806/j.cnki.issn.1004-3934.2024.04.016
摘要:
目的 探讨急性Stanford A型主动脉夹层（ATAAD）患者入院时腺苷脱氨酶（ADA）血清水平与术后30天内全因死亡之间的关系。 方法 回顾性连续纳入2013年11月 —2023年12月河北医科大学第四医院确诊为ATAAD并行手术治疗的234例患者，随访术后30天全因死亡。logistic回归分析患者住院死亡的危险因素。ROC评价ADA对ATAAD患者术后30天死亡的预测作用。依据ADA最佳截断值分组并绘制Kaplan-Meier生存曲线。Cox回归亚组分析ADA与术后30天死亡的关系。 结果 logistic回归分析结果显示，ATAAD患者入院时血清ADA水平与术后30天死亡呈正相关（ OR=1.487，95%CI 1.222 ~1.809）。曲线下面积为0.744（95%CI 0.669~0.820，P<0.001)，敏感度57.1%，特异度78.7%。Kaplan-Meier生存曲线显示入院高水平ADA患者术后30天死亡率显著增加（log-rank，P<0.001）。亚组分析同样证实了入院高水平ADA与患者术后30天死亡率相关。结论 ATAAD患者入院血清ADA水平与术后短期死亡风险相关，对患者短期预后具有一定的预测价值。
Abstract:
Objective To investigate the relationship between serum adenosine deaminase(ADA) levels at admission in ATAAD patients and all-cause mortality within 30 days after surgery. Methods A retrospective analysis of 234 patients who diagnosed with ATAAD admitted to The Fourth Hospital of Hebei Medical University between November 2013 and December 2023. The all-cause mortality within 30 days post-operation was followed up. Logistic regression analysis w as used to identify independent risk factors for in-hospital mortality in ATAAD patients. ROC curve w as used to assess the predictive value of ADA for 30-day mortality in ATAAD patients with the optimal cutoff value. Kaplan-Meier survival curves were plotted based on the optimal cutoff value, and the log-rank test was used to compare in-hospital mortality among groups with different ADA levels. Univariate Cox regression was employed for subgroup analysis of the relationship between ADA and mortality. Results The results of the multivariate logistic regression analysis revealed a positive correlation between serum ADA levels at admission and in-hospital mortality in patients with acute Stanford type A aortic dissection ( OR=1.487, 95% CI 1.222~1.809). The area under the curve was 0.744(95% CI 0.669~0.820, P<0.001), with a cutoff value of 9.65 U/L, a sensitivity of 57.1%, and a specificity of 78.7%. Kaplan-Meier survival curve analysis showed a worse in-hospital survival with higher ADA levels. Univariate Cox regression subgroup analysis demonstrated an effectiveness of high ADA levels on mortality across different subgroups. Conclusion The ADA levels at admission in ATAAD patients may be a predictor associated with postoperative in-hospital mortality and the short-term prognosis

参考文献/References:

[1]Zhou Z,Cecchi AC,Prakash SK,et al. Risk factors for thoracic aortic dissection[J]. Genes(Basel),2022,13(10):1814.

[2]Pape LA,Awais M,Woznicki EM,et al. Presentation,diagnosis,and outcomes of acute aortic dissection:17-year trends from the International Registry of acute aortic dissection[J]. J AM Coll Cardiol,2015,66(4):350-358.

[3]Evangelista A,Isselbacher EM,Bossone E,et al. Insights from the international registry of acute aortic dissection:A 20-year experience of collabrative clinical research[J]. Circulation,2018,137(17):1846-1860.

[4]Waterford SD,Eusanio MD,Ehrlich MP,et al. Postoperative myocardial infarction in acute type A aortic dissection:A report from the International Registry of Acute Aortic Dissection[J]. J Thorac Cardiovasc Surg,2017,153(3):521-527.

[5]Xu Y,Dai ST,Lin LZ,et al. Risk factors for?postoperative acute kidney injury in?overweight patients with?acute type A?aortic dissection[J]. J Cardiothorac Surg,2023,18(1):115.

[6]Luo ZR,Yu LL,Chen LW. Surgical outcomes associated with sleep apnea syndrome in Stanford A aortic dissection patients[J]. BMC Cardiovasc Disord,2022,22(1):329.

[7]Nienaber CA,Clough RE,Sakalihasan N,et al. Aortic dissection[J]. Nat Rev Dis Primers,2016,2:16053.

[8]Samanidis G,Kanakis M,Perreas K. Does systematic immune-inflammation index predict the short outcomes after an acute type A aortic dissection repair? Promising biomarker for acute aortic syndrome[J]. J Card Surg,2022,37(4):976-977.

[9]Flinn AM ,Gennery AR. Adenosine deaminase deficiency:a review[J]. Orphanet J Rare Dis,2018,13(1):65.

[10]Shaw KL,Garabedian E,Mishra S. Clinical efficacy of gene-modified stem cells in adenosine deaminase-deficient immunodeficiency[J]. J Clin Invest,2017,127(5):1689-1699.

[11]Lee PY,Daviason BA,Abraham RS,et al. Evaluation and management of deficiency of adenosine deaminase 2: An international consensus statement[J]. JAMA Netw Open,2023,6(5):e2315894.

[12]Huang F,Li XF,Zhang ZL,et al. Comparison of two surgical approaches for acute type A aortic dissection: hybrid debranching versus total arch replacement[J]. J Cardiothorac Surg,2022,17(1):166.

[13]Suzuki T,Eagle KA. Biomarker-Assisted diagnosis of acute aortic dissection[J]. Circulation,2018,137(3):270-272.

[14]Yuan Y,Xia ZY,Wang L, et al. Risk factors for in-hospital death in 2179 patients with acute aortic dissection[J]. Front Cardiovasc Med,2023 ,10:1159475.

[15]Yu M,Zhou H,Li Q,et al. Serum adenosine deaminase as a useful marker to estimate coronary artery calcification in type 2 diabetes mellitus patients[J]. Clin Appl Thromb Hemost,2021,27:1076029621999722.

[16]Ling Y,Jiang C,Xiao Z,et al. Serum adenosine deaminase activity and acute cerebral infarction: a retrospective case-control study based on 7913 participants[J]. Aging (Albany NY),2022,14(21):8719-8728.

[17]Palma RM,Bielsa S,Esquerda A,et al. Diagnostic accuracy of pleural fluid adenosine deaminase for diagnosing tuberculosis. Meta-analysis of Spanish studies[J]. Arch Bronconeumol,2019,55(1):23-30.

[18]Tang R,Ma CS,Dong JZ,et al. Does adenosine deaminase play a key role in coronary artery disease[J]. Med Hypotheses,2006,67(2):371-374.

[19]Toczek M,Kutryb-Zajac B,Zukowska P,et al. Changes in cardiac nucleotide metabolism in Huntington’s disease[J]. Nucleotides Nucleic Acids,2016,35(10-12):707-712.

[20]Kouzu H,Miki T,Tanno M,et al. Excessive degradation of adenine nucleotides by up-regulated AMP deaminase underlies afterload-induced diastolic dysfunction in the type 2 diabetic heart[J]. J Mol Cell Cardio,2015,80:136-145.

[21]Cai D,Sun C,Murashita T,et al. ADAR1 non-editing function in macrophage activation and abdominal aortic aneurysm[J]. Circ Res,2023,132(4):e78-e93.

[22]Zhang XC,Gao XT,Hu J,et al. ADAR1p150 forms a complex with dicer to promote miRNA-222 activity and regulate PTEN expression in CVB3-induced viral myocarditis[J]. Int J Mol Sci,2019,20(2):407.

[23]Oguro R,Kamide K,Katsuya T,et al. A single nucleotide polymorphism of the adenosine deaminase,RNA-specific gene is associated with the serum triglyceride level,abdominal circumference, and serum adiponectin concentration[J]. Exp Gerontol,2012,47(2):183-187.

[24]Chen J,Jin JY,Jiang J,et al. Adenosine deaminase acting on RNA1(ADAR1) as crucial regulators in cardiovascular disease:structures, pathogenesis, and potential therapeutic approach[J]. Front Pharmacol,2023,14:119884.

[25]Sun H,Men C,Deng H,et al. Construction of a nomogram model to identify atherosclerotic cardiovascular disease in patients with type 2 diabetes mellitus[J]. Discov Med,2023,35(179):1114-1122.

[26]Rabbi MF,Ahmed MN,Patowary MSA,et al. Pleural fluid adenosine deaminase to serum C-reactive protein ratio for diagnosing tuberculous pleural effusion[J]. BMC Pulm Med,2023,23(1):349.

相似文献/References:

[1]胡铁 王晓明.急性Stanford A型主动脉夹层的弓部手术策略及远期预后[J].心血管病学进展,2021,(5):433.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.012]
　HU Tie,WANG Xiaoming.Surgical Strategy and Long-Term Prognosis of Acute Stanford Type A Aortic Dissection[J].Advances in Cardiovascular Diseases,2021,(4):433.[doi:10.16806/j.cnki.issn.1004-3934.2021.05.012]
[2]李静 沈骁 孙加奎 孙芳 薛寅莹 章文豪 章淬.急性Stanford A型主动脉夹层术后膈肌功能障碍的临床研究[J].心血管病学进展,2022,(7):657.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
　LI Jing,SHEN Xiao,SUN Jiakui,et al.Clinical Study of Diaphragmatic Dysfunction After Surgical Treatment of Acute Stanford Type A Aortic Dissection[J].Advances in Cardiovascular Diseases,2022,(4):657.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
[3]高珩 邓超 李媛媛 钟亮 王雪.急性Stanford A型主动脉夹层患者术前炎症、凝血相关标志物及肌酐清除率与术后死亡的关系研究[J].心血管病学进展,2022,(12):1134.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.018]
　GAO Heng,DENG Chao,LI Yuanyuan,et al.Relationship of Preoperative Inflammation and Clotting Related Biomarkers ,Creatinine Clearance Rate with Postoperative Death in Patients with Acute Stanford Type A Aortic Dissection[J].Advances in Cardiovascular Diseases,2022,(4):1134.[doi:10.16806/j.cnki.issn.1004-3934.2022.12.018]

更新日期/Last Update: 2025-05-16